Mahesh Krishnan

Director, CHINOOK THERAPEUTICS, INC.

Companies

Halozyme TherapeuticsBoard member Apr 25, 2024 to now¹
CHINOOK THERAPEUTICS, INC.Board member Mar 29, 2022 to Aug 11, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Halozyme Therapeutics HALO14,462 shares³$1.8M at $121.51Jun 29, 2026
CHINOOK THERAPEUTICS, INC.0 shares⁴Aug 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 29, 2026Sold 7,304 shares at $75.00 of Halozyme Therapeutics³
Jun 29, 2026Exercised options 7,304 shares at $38.46 of Halozyme Therapeutics³
May 5, 2026Granted 3,796 shares of Halozyme Therapeutics⁵
May 1, 2025Granted 4,165 shares of Halozyme Therapeutics⁶
Apr 25, 2024Granted 6,501 shares of Halozyme Therapeutics⁷
Aug 11, 2023Returned to company 1,275 shares of CHINOOK THERAPEUTICS, INC.⁴
Apr 4, 2023Sold 924 shares at $23.01 of CHINOOK THERAPEUTICS, INC.⁸
Apr 1, 2023Exercised options 2,199 shares of CHINOOK THERAPEUTICS, INC.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHalozyme Therapeutics, Board member
2
SEC EDGARCHINOOK THERAPEUTICS, INC., Board member
3
SEC EDGARHalozyme Therapeutics shares after the filing of Jun 29, 2026
4
SEC EDGARCHINOOK THERAPEUTICS, INC. shares after the filing of Aug 11, 2023
5
SEC EDGARForm 4 filed May 7, 2026
6
SEC EDGARForm 4 filed May 2, 2025
7
SEC EDGARForm 4 filed Apr 29, 2024
8
SEC EDGARForm 4 filed Apr 4, 2023